Arcus Biosciences, Inc. (RCUS)

24.42 +0.59 (+2.48%) USD  |  NYSE  |  Oct 09, 16:00
24.42 0.00 (0.00%) After-Hours: 20:00
More

Arcus Biosciences EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for RCUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2021. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
December 31, 2023 --
Date Value
December 31, 2022 --
December 31, 2021 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
AVITA Medical, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Editas Medicine, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade